In AML, fat mass and obesity-associated protein (FTO), an N6-methyladenosine (m6A) demethylase, contributes to carcinogenesis by preventing the expression of immune checkpoint genes, particularly LILRB4. The gene discussed is FTO; the disease is acute myeloid leukemia.